These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 34465471

  • 1. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Baqui AH, Koffi AK, McCollum ED, Roy AD, Chowdhury NH, Rafiqullah I, Ahmed ZB, Mahmud A, Begum N, Ahmed S, Khanam R, Harrison M, Simmons N, Hossen S, Islam M, Quaiyum A, Checkley W, Santosham M, Moulton LH, Saha SK, Projahnmo Study Group in Bangladesh.
    Vaccine; 2021 Sep 24; 39(40):5794-5801. PubMed ID: 34465471
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh.
    Malaker R, Hasanuzzaman M, Hooda Y, Rahman H, Chandra Das R, Kanon N, Saha S, Tanmoy AM, Ranjan Chakraborty S, Saha S, Islam M, Darmstadt GL, Baqui AH, Sathosam M, El-Arifeen S, Whitney CG, Saha SK.
    Vaccine; 2024 Jan 12; 42(2):255-262. PubMed ID: 38071104
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    McCollum ED, Ahmed S, Roy AD, Chowdhury NH, Schuh HB, Rizvi SJR, Hanif AAM, Khan AM, Mahmud A, Pervaiz F, Harrison M, Reller ME, Simmons N, Quaiyum A, Begum N, Santosham M, Checkley W, Moulton LH, Baqui AH, Projahnmo Study Group in Bangladesh.
    Vaccine; 2020 Sep 29; 38(42):6508-6516. PubMed ID: 32873404
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pneumococcal Conjugate Vaccine impact assessment in Bangladesh.
    Baqui AH, McCollum ED, Saha SK, Roy AK, Chowdhury NH, Harrison M, Hanif AAM, Simmons N, Mahmud A, Begum N, Ahmed S, Khan AM, Ahmed ZB, Islam M, Mitra D, Quaiyum A, Chavez MA, Pervaiz F, Miele CH, Schuh HB, Khanam R, Checkley W, Moulton LH, Santosham M.
    Gates Open Res; 2018 Apr 26; 2():21. PubMed ID: 29984359
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan.
    Riaz A, Mohiuddin S, Husain S, Yousafzai MT, Sajid M, Kabir F, Rehman NU, Mirza W, Salam B, Nadeem N, Pardhan K, Khan KMA, Raza SJ, Arif F, Iqbal K, Zuberi HK, Whitney CG, Omer SB, Zaidi AKM, Ali A, Pakistan Pneumococcal Vaccine Study Group.
    Int J Infect Dis; 2019 Mar 26; 80():28-33. PubMed ID: 30576865
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL, Minamisava R, Policena G, Cristo EB, Domingues CM, de Cunto Brandileone MC, Almeida SC, Toscano CM, Bierrenbach AL.
    Hum Vaccin Immunother; 2016 Mar 26; 12(2):285-92. PubMed ID: 26905679
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic.
    Tomczyk S, Lessa FC, Sánchez J, Peña C, Fernández J, Gloria Carvalho M, Pimenta F, Cedano D, Whitney CG, Verani JR, Coradin H, Garib Z, De Oliveira LH, Feris-Iglesias J.
    BMC Infect Dis; 2018 Apr 02; 18(1):152. PubMed ID: 29609548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.
    Rinta-Kokko H, Auranen K, Toropainen M, Nuorti JP, Nohynek H, Siira L, Palmu AA.
    Vaccine; 2020 Feb 05; 38(6):1559-1564. PubMed ID: 31791813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.
    Kim JH, Chun BC, Song JY, Kim HY, Bae IG, Kim DM, Choi YH, Jun YH, Choi WS, Kang SH, Kwon HH, Jeong HW, Kee SY, Hur J, Chung JW, Yoon YK, Sohn JW, Yang KS, Kim MJ.
    Vaccine; 2019 May 09; 37(21):2797-2804. PubMed ID: 31005428
    [Abstract] [Full Text] [Related]

  • 18. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
    Thoon KC, Chong CY, Tee NW.
    Int J Infect Dis; 2012 Mar 09; 16(3):e209-15. PubMed ID: 22281191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.
    Su WJ, Lo HY, Chang CH, Chang LY, Chiu CH, Lee PI, Lu CY, Hsieh YC, Lai MS, Lin TY.
    Pediatr Infect Dis J; 2016 Apr 09; 35(4):e124-33. PubMed ID: 26974752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.